Swiss drugmaker Roche confirmed that the Indian government has partly revoked the patents granted for its breast cancer drug Herceptin. A company spokesperson it has received notification from the Kolkata Patent Office on July 17 that it has lifted divisional patents for Herceptin as they were not properly submitted. The announcement comes just a few days after India revoked GlaxoSmithKline's patent for its breast cancer drug Tykerb. "I can confirm ...Monday, 5 August 2013
Roche's Cancer Drug Patent Partly Revoked in India
Swiss drugmaker Roche confirmed that the Indian government has partly revoked the patents granted for its breast cancer drug Herceptin. A company spokesperson it has received notification from the Kolkata Patent Office on July 17 that it has lifted divisional patents for Herceptin as they were not properly submitted. The announcement comes just a few days after India revoked GlaxoSmithKline's patent for its breast cancer drug Tykerb. "I can confirm ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment